title: Experimental evaluation of combined immunotherapy for tumors.
abstract: The minimal vaccination dose of tumor cells was determined on experimental models. The effectiveness of antitumor immunotherapy with activated natural killer cells or dendritic cell vaccine (monotherapy or combined treatment) was evaluated in vivo. The inhibition of tumor growth was more pronounced after combination therapy with activated natural killer cells and dendritic cell-based vaccine. Our results indicate that the effectiveness of antitumor immunotherapy increases in simultaneous modulation of both immune components (innate and adaptive immunity).
authors.affiliation: N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow, Russia, irinashubona@mail.ru.
authors.forename: I Zh
authors.initials: IZh
authors.lastname: Shubina
authors.forename: N K
authors.initials: NK
authors.lastname: Akhmatova
authors.forename: F V
authors.initials: FV
authors.lastname: Donenko
authors.forename: M V
authors.initials: MV
authors.lastname: Kiselevskii
mesh_terms: D000818:Animals; D019496:Cancer Vaccines / Q000276:immunology / Q000627:therapeutic use*; D003713:Dendritic Cells / Q000276:immunology; D007694:Killer Cells, Natural / Q000276:immunology; D008297:Male; D008546:Melanoma, Experimental / Q000276:immunology / Q000628:therapy*; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA
chemical_list: D019496:Cancer Vaccines